I didn't want anyone getting the wrong impression. I wasn't
I didn't want anyone getting the wrong impression. I wasn't speaking of GC.
Dave, I really think you're a rascally playful puppy! A little bored and mischievous.
You know better than than to be surprised at what you have been saying would raise some "debate", if that's what you'd like to call it.
Your phrasing and choice of words are damming and you know it.
It is one thing to have hoped that the price would be X. It is another thing to have expected it and to raise "concerns" with GC's decisions.
You are 100% wrong in what you are accusing GC, the BOD and the BOA of doing or failing to do. And to claim otherwise is not only misleading but false!
You are 100% correct in you being concerned. But that's you.
Personally I wished you had stayed the course on YMB till 10.1. You rattled the cage quite well over there. But, you know better anyone one else, that you're not going to rattle the cage over here... Or for long. People will stop replying all altogether.
This board has been fact based. Show us GC's words and then show us failure. Not your translation or interpretation of failure.
If anyone were to read what you were saying this am, it sure sounds like your trying to buy more at a lower pps. But of course that's not what you're doing. Right? (Now that's a soft bash)
Cheers
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...
Continue Reading
University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...
Continue Reading
Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...
Continue Reading
A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...
Continue Reading
Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....
Continue Reading
The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...
Continue Reading
Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...
Continue Reading
PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...
Continue Reading
Top 5 Most Recently Viewed Articles
A Breath of Fresh Air in Purification In the chaotic race of technological innovation, it’s real sweet justice when something refreshingly simple stands out. Innova NanoJet's recent accolade as the Air Purification Technology Innovator of the Year 2026 at the UK Enterprise Awards is a big nod in the right direction. Spotting their NanoJet® Technology, which opts for a...
Continue Reading
Revolutionizing Cancer Diagnostics with AI In an exciting breakthrough within cancer diagnostics, Lunit has unveiled its Universal Immunohistochemistry (uIHC) AI model through extensive research published in npj Precision Oncology. This innovative model is designed to enhance accuracy in analyzing immunohistochemistry images, a key component in understanding cancer...
Continue Reading
Interest Rate Reduction Boosts Alvotech’s Financial Strategy Alvotech (NASDAQ: ALVO, ALVO SDB) is making waves in the biotech sector with its recent agreement from lenders to lower the interest rate on its senior secured term loan facility. This momentous shift is poised to decrease Alvotech's immediate financial burdens significantly, allowing for an estimated...
Continue Reading
Create a Global Impact with Seoul’s Brand Certification Seoul's vibrant culture and innovative spirit are now reaching new heights, thanks to the Seoul Business Agency (SBA). Under the leadership of CEO Hyun-woo Kim, the agency is expanding its product offerings associated with the prestigious Seoul Awards, bridging local innovations with global consumers. This...
Continue Reading
Understanding the Instrument Transformers Market Growth The global Instrument Transformers Market is expected to witness a significant transformation in the coming years. Current projections indicate that the market size will escalate from USD 7.1 billion in the present year to USD 10.6 billion by 2030. This represents an impressive compound annual growth rate (CAGR) of...
Continue Reading